Resmed (RSMDF) Gross Margin (2009 - 2026)
Resmed's (RSMDF) quarterly Gross Margin came in at 58.84% in Q2 2026, down 200.0% on a YoY basis from 58.84% in Q2 2025, and down 5.47% quarter-over-quarter from 62.25% in Q1 2026.
Powered by 
Analysis
Resmed (RSMDF) Gross Margin (2009 - 2026) Analysis & Trends
Resmed (RSMDF) has reported Gross Margin for 18 consecutive years, with 58.84% the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Gross Margin fell 200.0% year-over-year to 58.84%; the trailing twelve-month figure through Jun 2026 stood at 61.06% (up 169.0% YoY), and the FY2026 full-year result was 61.06%, up 169.0% from the prior year.
- Gross Margin fell to 58.84% in Q2 2026 per RSMDF's latest filing, from 62.25% in the prior quarter.
- Across five years, Gross Margin topped out at 62.25% in Q1 2026 and bottomed at 54.44% in Q3 2023.
- Historically, Gross Margin has averaged 58.07% across 5 years, with a median of 58.19% in 2024.
- The sharpest annual moves came in 2023 and 2024: Gross Margin tumbled 247 bps in 2023, then surged 414 bps in 2024.
- Over 5 years, Gross Margin stood at 56.08% in 2022, then dropped by 1 bps to 55.64% in 2023, then gained by 5 bps to 58.6% in 2024, then increased by 5 bps to 61.76% in 2025, then fell by 5 bps to 58.84% in 2026.
- According to Business Quant data, Gross Margin over the past three periods registered 58.84%, 62.25%, and 61.76% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.06 Bn | 178.46 Bn | 7.27 Bn | 57.71% |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | 67.78% |
| 3 | Medtronic | 118.26 Bn | 109.44 Bn | 6.34 Bn | 64.99% |
| 4 | Stryker | 104.56 Bn | 101.08 Bn | 4.50 Bn | 68.27% |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 70.71% |
| 6 | Edwards Lifesciences | 49.62 Bn | 45.37 Bn | 1.35 Bn | 77.46% |
| 7 | Alcon | 33.94 Bn | 32.48 Bn | 1.68 Bn | 60.21% |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | 63.44% |
| 9 | Steris | 21.14 Bn | 20.65 Bn | 684.20 Mn | 45.84% |
| 10 | Resmed | 3.54 Bn | 2.07 Bn | 861.22 Mn | 58.84% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 58.84% |
| Mar 31, 2026 | 62.25% |
| Dec 31, 2025 | 61.76% |
| Sep 30, 2025 | 61.46% |
| Jun 30, 2025 | 60.84% |
| Mar 31, 2025 | 59.33% |
| Dec 31, 2024 | 58.60% |
| Sep 30, 2024 | 58.57% |
| Jun 30, 2024 | 58.50% |
| Mar 31, 2024 | 57.88% |
| Dec 31, 2023 | 55.64% |
| Sep 30, 2023 | 54.44% |
| Jun 30, 2023 | 55.02% |
| Mar 31, 2023 | 55.31% |
| Dec 31, 2022 | 56.08% |
| Sep 30, 2022 | 56.91% |
| Jun 30, 2022 | 57.12% |
| Mar 31, 2022 | 56.82% |
| Dec 31, 2021 | 56.36% |
| Sep 30, 2021 | 56.00% |